The collaboration between two Danish companies aims to revolutionize drug discovery with help from quantum computing, AI and computer-aided drug design. COPENHAGEN, Denmark, May 30, 2024
Tetra Pharm Technologies and Glysious Announce Collaboration to Develop Transdermal Combination Drugs Targeting the Endocannabinoid System finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Following the successful filing of Intellectual Property (IP) for their applied platform technology targeting the endocannabinoid system (ECS),.
/PRNewswire/ Following convincing results from a recent In-Vitro study, the Danish biotech company, Tetra Pharm Technologies, today announces successful.
/PRNewswire/ In a recent In-Vitro study of TPT0301, Tetra Pharm Technologies s novel drug delivery technology was compared against more commonly utilized.